Abstract
ABSTRACT
Objectives
To investigate the safety and clinical outcomes of hip arthroscopy performed during menstruation in reproductive‐age female patients, and to determine whether surgery during menstruation increases intraoperative risks or adversely affects postoperative recovery. Currently, clear clinical guidelines regarding the timing of elective orthopedic surgeries relative to the menstrual cycle are lacking, often leading to unnecessary surgical rescheduling. Therefore, this study aimed to provide evidence‐based guidance for perioperative management and optimal surgical scheduling, thereby addressing a critical clinical need.
Methods
This retrospective cohort study included reproductive‐age female patients who underwent hip arthroscopy at the First Medical Center of Chinese PLA General Hospital, the Fourth Medical Center of Chinese PLA General Hospital, and the Department of Sports Medicine at the Second Hospital of Shandong University from December 2018 to September 2023. Patients were categorized into the menstruation group (MP) and the non‐menstruation group (NMP) based on whether they were menstruating on the day of surgery. The NMP group consisted of equally sized ovulatory (OP) and luteal (LP) phases. Perioperative outcomes included: intraoperative blood loss, anesthetic dosage, operative time, hemoglobin (Hb) change (within 24 h postoperatively), prothrombin time (PT), and activated partial thromboplastin time (APTT). Postoperative outcomes included analgesic consumption, duration of analgesic use, time to first unassisted weight‐bearing ambulation, complications, and urinary tract infections. Functional outcomes were assessed at 24‐month follow‐up using the Visual Analog Scale (VAS), Modified Harris Hip Score (mHHS), International Hip Outcome Tool‐12 (iHOT‐12), Hip Outcome Score‐Activities of Daily Living (HOS‐ADL), and Hip Outcome Score‐Sports Specific Subscale (HOS‐SSS).
Results
Of 884 eligible patients, 28 were included in the MP group and 56 matched patients in the NMP group. Operative time, anesthetic use, Hb change, PT, and APTT were comparable between the two groups (all
p
> 0.05). No serious complications or urinary tract infections occurred in either group. At the 24‐month follow‐up, both groups demonstrated significant improvements in VAS, mHHS, iHOT‐12, HOS‐ADL, and HOS‐SSS (all
p
Conclusions
Hip arthroscopy during menstruation does not increase intraoperative bleeding, impair coagulation, or delay functional recovery for female patients. Menstruation should not be considered a contraindication when appropriate perioperative management is applied.